LENZ Therapeutics (NASDAQ:LENZ) Stock Quotes, Forecast and News Summary

Q: What sector and industry does LENZ Therapeutics (LENZ) operate in?

LENZ Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

LENZ Therapeutics Stock (NASDAQ: LENZ) stock price, news, charts, stock research, profile.

Open	$22.64
Close	$22.50
Volume / Avg.	143.40K / 164.44K
Day Range	$22.34 - $23.47
52 Wk Range	14.42 - 38.93
Market Cap	$618.77M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	-
Days to Cover	12.55

Recent News

LENZ Therapeutics' Investigational Drug For Age-Related Blindness Aces Pivotal China Trial, Analyst Says Data Readout May Strengthen Position For Ex-U.S. Partnerships

LENZ Therapeutics and Corxel Pharmaceuticals announced Phase 3 data for LNZ100, showing significant presbyopia improvements, supporting potential FDA approval.

Vandana Singh

Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why LENZ Therapeutics Stock Hit A New 52-Week High Today

Lenz Therapeutics shares hit a new 52-week high during Monday's session. The company announced the FDA accepted its new drug application.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$22.64
Close	$22.50
Volume / Avg.	143.40K / 164.44K
Day Range	$22.34 - $23.47
52 Wk Range	14.42 - 38.93
Market Cap	$618.77M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	-
Days to Cover	12.55

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy LENZ Therapeutics (LENZ) stock?

You can purchase shares of LENZ Therapeutics (NASDAQ:LENZ) through any online brokerage.

View our list of the best stock brokerages

Who are LENZ Therapeutics (LENZ) competitors?

Other companies in LENZ Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA) and Upstream Bio (NASDAQ:UPB).

What is the forecast, or price target, for LENZ Therapeutics (LENZ) stock?

LENZ Therapeutics has a consensus price target of $35.40.

What is the current price for LENZ Therapeutics (LENZ)?

The stock price for LENZ Therapeutics (NASDAQ: LENZ) is $22.5 last updated January 17, 2025 at 4:00 PM EST.

Does LENZ Therapeutics (LENZ) pay a dividend?

A quarterly cash dividend of 1.03 per share of Class A Common Stock. The quarterly cash dividend was payable on March 22, 2024 to stockholders of record on March 15, 2024.

When is LENZ Therapeutics (NASDAQ:LENZ) reporting earnings?

LENZ Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is LENZ Therapeutics (LENZ) going to split?

There is no upcoming split for LENZ Therapeutics.

What sector and industry does LENZ Therapeutics (LENZ) operate in?

LENZ Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

LENZ Therapeutics

LENZ Therapeutics (LENZ) Forecast